# F-X233, acceptance record, pass 1

**Reviewed**: canonical sprint/s93 working diff against HEAD, exactly three existing documentation files, four inserted and three removed lines. Read the approved F-X233 plan and prior independent source and metadata reviews. No source, documentation, scratch, baseline or commit changes were made during this audit.
**Verdict**: 0 defects, 0 smells, 0 nitpicks

## Defects

None found.

## Smells

None found.

## Nitpicks

None found.

## Contract checks

The existing plan explicitly records the user-approved order: take an actual
15point sz120 screenshot, then retain a distinct raw15 sz15 control if needed.
Both remain inferred candidates rather than the original document
(`.claude/plans/F-X233-design.md:27`). It also retains the unavailable-original
limit after native qualification and excludes exact-original and full-page
font-contour parity claims (`.claude/plans/F-X233-design.md:95`).

The HLD14 replacement matches that existing authorization. Original input is
preferred when available, while the approved inferred controls carry an
explicit prohibition on claiming exact-original reproduction. Saved size and
space inspection, independent geometry and native comparison, and unchanged
raster thresholds remain required
(`docs/hld/14-development-backlog.md:7980`). The added HLD impact entry names
only this acceptance wording (`.claude/plans/F-X233-design.md:129`). It adds no
implementation, public API or verification scope.

CURRENT sequencing now describes the actual missing-original condition and
retains the distinction among width, clearance, clipping and joins
(`docs/sprints/CURRENT_SPRINT.md:34`). Its definition of done binds native
paint evidence to the approved inferred inputs and explicitly preserves both
the raster thresholds and reproduction limit
(`docs/sprints/CURRENT_SPRINT.md:44`). It does not assert whole-paint or
whole-page equality, and it leaves the plan's narrower qualification limits
intact.

## Not found

- Scope expansion: none. All changed wording reconciles delivery records with the already approved diagnostic interpretation.
- Exact-original claim: none. The new HLD and sprint wording explicitly retain its absence.
- Broader paint claim or relaxed tolerance: none. Independent component evidence and existing thresholds remain the contract.
- Source or baseline change: none in the reviewed diff.

This narrow documentation pass ends here. Return to sprint orchestration.
